Carregant...
Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
BACKGROUND: The development of heart failure is accompanied by complex changes in cardiac electrophysiology and functional properties of cardiomyocytes and fibroblasts. Histone deacetylase (HDAC) inhibitors hold great promise for the pharmaceutical therapy of several malignant diseases. Here, we des...
Guardat en:
| Publicat a: | BMC Pharmacol Toxicol |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6404297/ https://ncbi.nlm.nih.gov/pubmed/30841920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-019-0294-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|